Is it safe to take Meclizine (meclizine) and Reglan (metoclopramide) at the same time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Concurrent Use of Meclizine and Metoclopramide (Reglan)

Yes, meclizine and metoclopramide can be safely used together, and this combination is specifically supported in clinical guidelines for managing nausea and vomiting, particularly when emergency contraception is needed. 1

Evidence for Concurrent Use

The most direct evidence comes from the CDC's 2024 contraceptive guidelines, which explicitly studied this combination:

  • Meclizine taken before metoclopramide significantly reduces nausea and vomiting when both drugs are used together for emergency contraception protocols 1
  • Two clinical trials specifically evaluated antiemetic pretreatment (meclizine and metoclopramide) and found that meclizine reduced both the severity of nausea AND the occurrence of vomiting when given before combined hormonal emergency contraceptives 1

Complementary Mechanisms of Action

These medications work through different pathways, making their combination logical:

  • Meclizine is an antihistamine that blocks H1 receptors centrally, providing antiemetic effects primarily through the vestibular system and chemoreceptor trigger zone 2, 3
  • Metoclopramide (Reglan) is a dopamine antagonist that works both centrally at the chemoreceptor trigger zone AND peripherally by increasing gastric emptying and lower esophageal sphincter tone 4, 5

Clinical Applications Where This Combination Is Useful

For Nausea/Vomiting Prevention

  • Pretreat with meclizine 25-50 mg, then give metoclopramide 10 mg when anticipating significant nausea risk 1, 6
  • This approach is particularly effective for medication-induced nausea (such as emergency contraceptives or chemotherapy-related nausea) 1

For Hiccups

  • Metoclopramide 10 mg three to four times daily can be used as primary therapy 7
  • Meclizine could theoretically be added for concurrent nausea, though guidelines don't specifically address this combination for hiccups 7, 8

Important Safety Considerations

Sedation Risk

  • Both medications cause drowsiness and sedation - this is the primary concern with concurrent use 4, 5, 3
  • Meclizine causes sleepiness, tiredness, and concentration problems 3
  • Metoclopramide causes drowsiness and lassitude in up to 20% of patients 5
  • Warn patients about additive sedation and avoid driving or operating machinery 3

Metoclopramide-Specific Warnings

  • Limit metoclopramide duration to short-term use (days to weeks, not months) due to risk of tardive dyskinesia with prolonged use 7, 8
  • Monitor for extrapyramidal symptoms including dystonic reactions, akathisia, and muscle rigidity 7, 5
  • Use caution in patients with seizure disorders, GI bleeding, or GI obstruction 8
  • Consider having diphenhydramine available to treat potential dystonic reactions from metoclopramide 7

Meclizine-Specific Considerations

  • Meclizine has a slower onset (approximately 1 hour) compared to IV metoclopramide 2
  • Common side effects include blurred vision and dizziness in addition to sedation 3

Practical Dosing Approach

For acute nausea/vomiting:

  • Meclizine 25-50 mg orally 30-60 minutes before metoclopramide 1, 6
  • Metoclopramide 10 mg orally or IV as needed 7

For ongoing symptoms:

  • Metoclopramide 10 mg three to four times daily (primary agent) 7
  • Meclizine 25-50 mg once or twice daily as adjunct for breakthrough nausea 6

When to Avoid This Combination

  • Patients requiring alertness for work or driving (due to additive sedation) 3
  • Elderly patients at higher risk for falls and cognitive impairment 8
  • Patients with pre-existing movement disorders (metoclopramide contraindication) 8
  • When metoclopramide has already been used long-term (>12 weeks) due to tardive dyskinesia risk 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Metoclopramide: a dopamine receptor antagonist.

American family physician, 1990

Research

Metoclopramide: pharmacology and clinical application.

Annals of internal medicine, 1983

Guideline

Combination Therapy for Intractable Hiccups

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoclopramide for Hiccups

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.